Tardive Dyskinesia
13 drugs23,689 FAERS reportsMedDRA PT
GET
/api/v1/reaction/tardive-dyskinesiaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D000071057
Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).
Source: U.S. National Library of Medicine — MeSH (Tardive Dyskinesia)
Drugs reporting Tardive Dyskinesia (13)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Metoclopramide16,21821%
- 2Valbenazine1,4966.1%
- 3Perphenazine1024.9%
- 4Thiothixene104.6%
- 5Cariprazine3604.0%
- 6Brexpiprazole5933.7%
- 7Ziprasidone7293.7%
- 8Deutetrabenazine2403.5%
- 9Lumateperone1742.8%
- 10Lurasidone5622.7%
- 11Benztropine1742.4%
- 12Aripiprazole2,8692.3%
- 13Tetrabenazine1622.2%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
Literature
Recent PubMed references pinned to Tardive Dyskinesia as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Electroconvulsive Therapy for Severe Refractory Tardive Dystonia Without Active Depression: A Case Report.Neuropsychopharmacology reports · 2026 · Asahi T, Kawamata Y, Sugawara N, et al.PMID 42152530DOI 10.1002/npr2.70128
- Genetics of tardive dyskinesia: a review of progress over the past decade.Pharmacogenomics · 2026 · Zai CC, Thamilselvan M, Chernous F, et al.PMID 42148524DOI 10.1080/14622416.2026.2673123
- Cross-Dataset Evaluation of an Automated Video-Based Model for Detecting Tardive Dyskinesia Using the Clinician's Tardive Inventory: Validation Study.JMIR mental health · 2026 · Trosch R, Sterns A, Grimm B, et al.PMID 42133936DOI 10.2196/92197
- Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials.The Journal of clinical psychiatry · 2026 · Bron M, Mathias SD, Stull DE, et al.PMID 42095693DOI 10.4088/JCP.25nr16047
- Tardive dyskinesia and cognitive performances in late-life depression: a sex-stratified analysis.Psychiatry research · 2026 · Luca A, Luca M, Drago F, et al.PMID 42030922DOI 10.1016/j.psychres.2026.117185
- Adjunctive cerebellar anodal transcranial direct current stimulation for tardive dyskinesia in patients with SchIzophrenia: An open-label pilot study.Asian journal of psychiatry · 2026 · Mathew N, Mandal S, Panda SP, et al.PMID 41950719DOI 10.1016/j.ajp.2026.104969
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.